Santen Pharmaceutical Co., Ltd. Appoints Tatsuya Kaihara as Corporate Officer and Head of North America Business
April 01, 2020 at 09:38 am EDT
Share
Santen Inc. announced the appointment of Tatsuya Kaihara as Corporate Officer and Head of North America Business of Santen Pharmaceutical. As of April 1, he is also appointed as CEO of Santen Inc. and he will lead
the company's North America business and report to Shigeo Taniuchi, President and CEO of Santen Pharmaceutical. Since joining Santen in 2017, Kaihara has served as Chief Strategy Officer and Deputy Chief Executive and Financial Officer of Santen Inc. He also held the position of Chief Investment Officer for Santen Ventures Inc., the company's North American corporate ventures capital fund which invests in research and development projects and partners focused on innovations in ophthalmology.
SANTEN PHARMACEUTICAL CO., LTD. is a Japan-based pharmaceutical company engaged in the research, development, manufacturing and sales of pharmaceutical products. The Company has medical pharmaceutical business, OTC drugs business, medical devices business and other businesses. The Company engages in manufacture, sale and clinical development of medical pharmaceutical products, the development, manufacturing and sales of medical equipment, as well as the cleaning business. The Company operates in Japan, Europe, Asia, North America markets.